Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederic J Kaye

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Cancer Investigation|July 25, 2018
Stereotactic Ablative Body Radiotherapy for Primary Non-Small-Cell Lung Cancer: Achieving Local Control with a Lower Biologically Effective DoseSimeng Zhu, Judith L Lightsey, Bradford S Hoppe, et al.
Cancer Genetics|July 9, 2013
Integrated high-resolution array CGH and SKY analysis of homozygous deletions and other genomic alterations present in malignant mesothelioma cell linesGeula Klorin, Ester Rozenblum, Oleg Glebov, et al.
Oncotarget|January 17, 2019
CDK4/6 inhibition stabilizes disease in patients with p16-null non-small cell lung cancer and is synergistic with mTOR inhibitionPriya K Gopalan, Andres Gordillo Villegas, Chunxia Cao, et al.
Oncogene|April 27, 2023
TYMS promotes genomic instability and tumor progression in Ink4a/Arf null backgroundMaria V Guijarro, Akbar Nawab, Peter Dib, et al.
Iscience|December 9, 2025
Integrated proteomic analysis identifies TYMS-dependent AMPK-mTOR signaling in pancreatic neuroendocrine tumorsVinod Vijayakurup, Benjamin Meyer, Syeda Rida Rizvi, et al.
The Oncologist|May 7, 2020
Delta-Like Protein 3 Expression and Targeting in Merkel Cell CarcinomaHao Xie, Frederic J Kaye, Kumiko Isse, et al.
Cancers|May 14, 2022
Reducing Chemotherapy-Induced DNA Damage via nAChR-Mediated Redox Reprograming-A New Mechanism for SCLC Chemoresistance Boosted by NicotineYuzhi Wang, Tengfei Bian, Lina Song, et al.
International Journal of Cancer|December 19, 2013
Analysis of 320 gastroenteropancreatic neuroendocrine tumors identifies TS expression as independent biomarker for survivalHye Seung Lee, Min Chen, Ji Hun Kim, et al.
Elife|June 18, 2021
Dependency of human and murine LKB1-inactivated lung cancer on aberrant CRTC-CREB activationXin Zhou, Jennifer W Li, Zirong Chen, et al.
Nature Genetics|January 23, 2003
t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathwayGiovanni Tonon, Sanjay Modi, Lizi Wu, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Cancer Investigation|July 25, 2018
Stereotactic Ablative Body Radiotherapy for Primary Non-Small-Cell Lung Cancer: Achieving Local Control with a Lower Biologically Effective DoseSimeng Zhu, Judith L Lightsey, Bradford S Hoppe, et al.
Cancer Genetics|July 9, 2013
Integrated high-resolution array CGH and SKY analysis of homozygous deletions and other genomic alterations present in malignant mesothelioma cell linesGeula Klorin, Ester Rozenblum, Oleg Glebov, et al.
Oncotarget|January 17, 2019
CDK4/6 inhibition stabilizes disease in patients with p16-null non-small cell lung cancer and is synergistic with mTOR inhibitionPriya K Gopalan, Andres Gordillo Villegas, Chunxia Cao, et al.
Oncogene|April 27, 2023
TYMS promotes genomic instability and tumor progression in Ink4a/Arf null backgroundMaria V Guijarro, Akbar Nawab, Peter Dib, et al.
Iscience|December 9, 2025
Integrated proteomic analysis identifies TYMS-dependent AMPK-mTOR signaling in pancreatic neuroendocrine tumorsVinod Vijayakurup, Benjamin Meyer, Syeda Rida Rizvi, et al.
The Oncologist|May 7, 2020
Delta-Like Protein 3 Expression and Targeting in Merkel Cell CarcinomaHao Xie, Frederic J Kaye, Kumiko Isse, et al.
Cancers|May 14, 2022
Reducing Chemotherapy-Induced DNA Damage via nAChR-Mediated Redox Reprograming-A New Mechanism for SCLC Chemoresistance Boosted by NicotineYuzhi Wang, Tengfei Bian, Lina Song, et al.
International Journal of Cancer|December 19, 2013
Analysis of 320 gastroenteropancreatic neuroendocrine tumors identifies TS expression as independent biomarker for survivalHye Seung Lee, Min Chen, Ji Hun Kim, et al.
Elife|June 18, 2021
Dependency of human and murine LKB1-inactivated lung cancer on aberrant CRTC-CREB activationXin Zhou, Jennifer W Li, Zirong Chen, et al.
Nature Genetics|January 23, 2003
t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathwayGiovanni Tonon, Sanjay Modi, Lizi Wu, et al.
Pageof 8